Loading company…
Occlutech develops minimally invasive cardiac devices for congenital heart disease, stroke prevention and heart failure.
Founded in 2003 and headquartered in Helsingborg, Sweden, Occlutech designs, manufactures and commercializes minimally invasive cardiac devices. Its latest funding round was led by Interlink Investment Group, totaling EUR 15 million on August 24, 2011. CEO Birol Balci leads the company, which supplies hospitals, clinics and heart treatment centers in Europe, Asia and the Americas. In 2022 it generated revenue of EUR 27,767,644.10 and EBITDA of EUR 2,356,675.80.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in